Podcasts about treatments

Following a divorce, Ken's daughter struggled with repeated behavioral and emotional challenges that intensified over time. Now 22 years old and recently completing treatment for depression, she needs a stable place to live while continuing her recovery.  Call 1-800-DR-LAURA / 1-800-375-2872 or make an appointment at DrLaura.com Follow me on social media: Facebook.com/DrLaura Instagram.com/DrLauraProgram YouTube.com/DrLaura Join My Family!! Receive my Weekly Newsletter + 20% off my Marriage 101 course & 25% off Merch! Sign up now, it's FREE! Each week you'll get new articles, featured emails from listeners, special event invitations, early access to my Dr. Laura Designs Store benefiting Children of Fallen Patriots, and MORE! Sign up at DrLaura.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Up to 40 percent of infertility cases involve combined male and female factors, but the male partner is often skipped. Erica Bove, a reproductive endocrinology and infertility specialist, returns to discuss why that gap exists and what can be done about it. This episode is based on her article "What is often overlooked about male factor infertility," published on KevinMD. You will hear how prescribed testosterone for low energy and low sex drive can wipe out sperm production, sometimes irreversibly, and why men taking it for low T frequently have no idea their fertility is at stake. You will learn what a basic semen analysis screens for and what a full male evaluation adds, including hormonal testing and a reproductive urologist exam. You will hear how varicocele surgery alone can resolve a couple's infertility, why marijuana and tobacco are unusually bad for sperm, and why every change shows up three months later. Press play to find out which male factor causes are most often missed, and which are most often reversible. True team-based care starts with you. At ChenMed, we believe the best way to care for patients is to change the way we practice medicine. When you join our team, you are empowered to lead. We've moved beyond the traditional volume-heavy model to focus on true value-based care. Our model gives you the time and resources to manage complex cases and make a lasting impact on your community. Whether you are applying for a primary care physician, nurse practitioner, or medical director position, you will feel supported by a physician-led culture that understands your challenges. Your dedication doesn't go unnoticed here. You'll be rewarded with a career that offers both professional fulfillment and a better quality of life. Visit ChenMed.com/physicians-KevinMD to learn more. VISIT SPONSOR → https://ChenMed.com/physicians-KevinMD Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

🧭 REBEL Rundown Click here for Direct Download of the Podcast. 💨 What Is Nitrous Oxide? Nitrous Oxide (N2O) is a colorless, odorless inhaled anesthetic that has been used for centuries, particularly in the surgical world. Mechanistically, it can induce euphoria, anxiolysis, and intoxication via NMDA receptor antagonism.During the late twentieth century, nitrous oxide was increasingly used recreationally due its accessibility and perceived benign nature.The modern day slang term for nitrous oxide is “whippets” – which tends to refer to the canisters that contain this agent and are frequently used as whipped cream foaming agents.Despite the legal nature and benign perception of nitrous, frequent use can lead to lasting and permanent neurologic effects. 🧠 How Nitrous Oxide Causes Toxicity Nitrous oxide toxicity results from its ability to oxidize the cobalt moiety in Vitamin-B12, thus leading to a functional B12 deficiency, despite adequate consumption and absorption.1Functioning B12 is needed as a cofactor for methionine synthase.2 This enzyme has two critical roles:The conversion of 5-methyl tetrahydrofolate to tetrahydrofolate; tetrahydrofolate is essential for the synthesis of our DNA.And the conversion of homocysteine to methionine; methionine is needed to maintain the integrity of the myelin sheath of our axons.As a result, nitrous toxicity leads to: a megaloblastic anemia and demyelination of both the dorsal columns and the lateral corticospinal tracts (also known as subacute combined degeneration). 🚶‍️ Clinical Manifestations of Nitrous Oxide Toxicity These patients will have a combination of both upper and lower motor neuron symptoms due to demyelination of the dorsal columns, lateral corticospinal tracts, and peripheral nerves. As a result, the following may manifest:Dorsal Columns: diminished sense of proprioception, vibration, and fine touch.Lateral Corticospinal Tracts: upgoing plantars, hyperreflexia, weakness of voluntary distal muscle controlPeripheral Nerves: numbness/tingling and weakness in a glove and stocking pattern (symptoms that start initially in the feet and hands that progressively spread proximally to the ankles and wrists)Taking all of this into account, patients may present with difficulty ambulating, positive Romberg sign, dysmetria (difficulty with finger to nose or heel to shin), upgoing Babinski reflex, and decreased strength and sensation in a glove and stocking pattern. 🔍 How to Diagnose Nitrous Oxide Neurotoxicity History is key! As with a lot of pathologies in toxicology, identifying the exposure will expedite management.A thorough neurologic exam will narrow the differential – with a particular focus to fine, peripheral motor and sensory deficits, dysmetria, proprioception, and ability to ambulate.Magnetic resonance imaging of the spine may identify enhancement and/or edema of the dorsal columns, specifically on T2 weight axial imaging – sometimes referred to as the “inverted V” or “inverted rabbit ears appearance.”3Serum B12 concentrations may be normal as the issue is with a functional deficiency as opposed to a vitamin absence. However, patients have elevated concentrations of both homocysteine and methylmalonic acid, both of which are metabolized in the presence of functional B12. 💉 Management of Nitrous Oxide Toxicity First and foremost, cessation of nitrous oxide abuse is crucial to limit/prevent toxicity.While there is no universally agreed upon treatment regimen, supplementation with intramuscular B12 is recommended.Approaches vary from daily or every other day injections until symptoms improve at which point injections can be spaced out to weekly and then monthly.Physical and occupational therapy may be needed depending on the degree of functional debility.It is important to note, that depending of the severity and chronicity of toxicity, some proportion of patients may not fully return to their baseline. 📌 Take-Home Points Though legal and seemingly benign, nitrous oxide abuse can lead to permanent neurologic dysfunction.Nitrous oxide toxicity can affect the dorsal columns, lateral corticospinal tracts, and peripheral nerves.Thus leading to a constellation of both upper and lower motor neuron deficits, particular in a glove and stocking pattern: deficits in proprioception and fine motor skills, positive Romberg, upgoing Babinski, peripheral numbness, tingling, and weakness.Magnetic resonance imaging may identify symmetric high signal intensity in the dorsal columns.Treatment includes B12 supplementation and physical/occupational therapy as needed. 📚 References Long H. Chapter 81. Inhalants. In: Nelson LS, et al. Goldfrank’s Toxicologic Emergencies. 11th ed. New York: McGraw-Hill; 2019Shah K, Murphy C. Nitrous Oxide Toxicity: Case Files of the Carolinas Medical Center Medical Toxicology Fellowship. J Med Toxicol. 2019 Oct;15(4):299-303. doi: 10.1007/s13181-019-00726-x. Epub 2019 Aug 6. PMID: 31388940; PMCID: PMC6825085.Schmitz ZP, Hoffman RS. Magnetic resonance imaging in a patient with nitrous oxide-induced subacute combined degeneration of the spinal cord. Clin Toxicol (Phila). 2023 Nov;61(11):1006-1008. doi: 10.1080/15563650.2023.2286205. Epub 2023 Dec 19. PMID: 38060330. Post Peer Reviewed By: Marco Propersi, DO (Twitter/X: @Marco_propersi), and Mark Ramzy, DO (X: @MRamzyDO) 👤 Associate Editor Anand Swaminathan MD, MPH All Things REBEL EM Meet The Team 🔎 Your Deep-Dive Starts Here REBEL Core Cast – Pediatric Respiratory Emergencies: Beyond Viral Season Welcome to the Rebel Core Content Blog, where we delve ... Pediatrics Read More REBEL Core Cast 143.0–Ventilators Part 3: Oxygenation & Ventilation — Mastering the Balance on the Ventilator When you take the airway, you take the wheel and ... Thoracic and Respiratory Read More REBEL Core Cast 142.0–Ventilators Part 2: Simplifying Mechanical Ventilation – Most Common Ventilator Modes Mechanical ventilation can feel overwhelming, especially when faced with a ... Thoracic and Respiratory Read More REBEL Core Cast 141.0–Ventilators Part 1: Simplifying Mechanical Ventilation — Types of Breathes For many medical residents, the ICU can feel like stepping ... Thoracic and Respiratory Read More REBEL Core Cast 140.0: The Power and Limitations of Intraosseous Lines in Emergency Medicine The sicker the patient, the more likely an IO line ... Procedures and Skills Read More REBEL Core Cast 139.0: Pneumothorax Decompression On this episode of the Rebel Core Cast, Swami takes ... Procedures and Skills Read More Showing Slide 1 of 7 The post REBEL Core Cast—Nitrous Oxide Toxicity: Whippets and Neurologic Injury appeared first on REBEL EM - Emergency Medicine Blog.

☎️ Book Your COMPLEMENTARY CONSULTATION and CALORIE CALCULATION Call: https://calendly.com/d/2p8-mxx-dgf/free-consultation-call-zoom⁠⁠⁠⁠⁠⁠PMOS guide: https://www.vitalityoet.com/pmosPCOS has officially been renamed PMOS - Polyendocrine Metabolic Ovarian Syndrome - published in The Lancet on May 12th, 2026, after 14 years of global collaboration. In this episode I share my own PMOS story - cortisol-induced, stress-driven, and masked by birth control for years.  What You'll LearnWhy PCOS was renamed PMOS and what each word in the new name actually meansStephanie's personal cortisol-driven PMOS story — and how birth control masked it for yearsWhat PMOS actually is, explained simply — androgens, the hormonal system, why symptoms happenThe four types of PMOS: insulin-resistant, adrenal/cortisol, inflammatory, and post-pillThe specific tests that reveal each type — including why fasting glucose misses most of themWhy the same diagnosis needs four different solutionsWhat the first move is for each type

Health Correspondent, Fergal Bowers reports on a review of governance and equity in patient access and waiting lists management at Children's Health Ireland.

Everywhere now, people are talking about weight loss. But what are the red flags we should watch out for when losing weight? What does healthy weight loss look like? What's making our faces look so tired, and how can we move towards undetectable beauty? Bianca Gonzalez sits down with Dr. Z Teo, CEO of The Aivee Group, to talk about what we might be getting wrong about weight loss, aesthetic treatments, and overall wellness. Thank you to Sculptra for partnering with us for this episode! To know more about Sculptra, you may visit Aesthetics by Galderma PH on Instagram (@aestheticsbygalderma.ph) or directly book a consultation at The Aivee Clinic (@theaiveeclinic) through their local numbers +63 917 728 3838 and +63 969 223 0499.

Recreation director in the Town of Lewiston, Tim Smith on the treatment for ticks at town parks full 337 Mon, 15 Jun 2026 08:30:00 +0000 6s6jb8y8Gk8Wr4rRw7tVeofgvvlgag7O news,wben,niagara county,ticks,lewiston WBEN Extras news,wben,niagara county,ticks,lewiston Recreation director in the Town of Lewiston, Tim Smith on the treatment for ticks at town parks Archive of various reports and news events 2024 © 2021 Audacy, Inc. News

Season 3 of Prostate Talk continues with a deep dive into one of the most important topics in prostate cancer care: precision.In this second episode, Maude Pavageau welcomes Dr. Eduard Baco to discuss the critical role of accurate image fusion in prostate biopsy.From improving targeting accuracy to helping reduce missed diagnoses and supporting more personalized treatment decisions, this conversation highlights how technology is reshaping the prostate cancer journey.

A new medication to treat schizophrenia has been developed by scientists who discovered that a neuron that inhibits the activity of other cells may be in short supply in those with the disorder.

Episode 73 of the Becoming Centered Podcast continues to look at how direct care staff can incorporate treatment interventions into every part of the residential day.  A lot of that involves interacting with the kids in a way that is consciously intended to promote in them a sense of belonging, a sense of purpose, a sense of agency, and a sense of meaning.  These qualities will make kids more resilient to the stressors and triggers in their lives.  Most staff have a good intuitive understanding of what sorts of structures and interactions are likely to make a client feel that sense of belonging.  How to help children and youth experience a sense of purpose in their residential experience is less intuitive.  It involves staff having a shared understanding of how to frame the residential treatment experience for the kids, how to explain it to them, and how to demonstrate that each kid is growing and learning from their experiences living in a treatment program. 

​EmSwizzle (Max) and cdotkom (Charlie) discuss that controversial Nintendo Direct and break down our full thoughts on the remake of The Legend of Zelda: Ocarina of Time, Nintendo Switch Sports Resort, we answer your questions, and SO MUCH MORE!​

This episode of RBC Pathfinders in Biopharma explores how next-generation retinal gene therapies could transform treatment for patients with wet AMD and diabetic macular edema. CCBO of 4D Molecular Therapeutics, Chris Simms, discusses the promise of reducing the burden of frequent injections through long-lasting therapies designed to preserve vision for years. The conversation also examines the firm's commercial opportunity, global roll-out ambitions, and why sustained retinal care could reshape the future of retina.

A crowd gathered at the Milwaukee Metropolitan Sewerage District headquarters for a meeting about what company should run MMSD's two wastewater treatment facilities in 2028.

Not all carpal tunnel cases are actually wrist problems. Let's talk about how to find the true source of the symptom so you can stop chasing symptoms and start getting better results.

Discover why California fans are flying to Seoul for advanced stem cell skin treatments. From BTS-fueled tourism to exosome facials that deliver 'mirror skin,' Korea's regenerative skincare revolution is reshaping beauty travel for ARMY and beyond. Lydian Cosmetic Surgery Clinic City: Seoul Address: 836 Nonhyeon-ro, Sinsa-dong, Gangnam Website: https://www.lydianclinic.com/

Will new PE guidelines redefine risk and therapy in pulmonary embolism (PE) care? In this episode of the BackTable podcast, host Dr. Michael Barraza is joined by interventional cardiologist Dr. Jay Giri and emergency physician Dr. Trevor Cummings to break down the latest changes in PE management. They discuss how multidisciplinary pulmonary embolism response teams (PERT) are implementing these guidelines at their institutions, the introduction of a more nuanced A-E risk stratification system, and the challenges of enrolling experienced centers into clinical trials as device innovation accelerates. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by Inari Medicalhttps://www.inarimedical.com/flowtriever-system --- Timestamps 00:00 - Introduction 01:24 - Building a PERT Team04:59 - Trials Shaping PE Care 10:20 - Why New Guidelines Now 14:06 - New Risk Categories Explained 19:51 - Applying Guidelines Locally 23:34 - What Is C1 Risk 27:52 - New D Category Explained 30:33 - Evidence for Aggressive Therapy 33:31 - How PERT Teams Communicate 38:22 - Upcoming PE Trials Pipeline 43:42 - Program Growth and High Risk Trials 45:46 - Closing Remarks --- More about this episode The conversation highlights the growth of catheter-directed lysis and mechanical thrombectomy, the rationale and practical impact of the new Category D for incipient cardiopulmonary failure (including normotensive shock), and the incorporation of PESI, sPESI, and Hestia for risk assessment. Additional topics include decision-making for low-risk patients, lactate and biomarkers for identifying higher-risk cases, communication strategies within PERT teams, AI-enabled risk stratification, and a preview of upcoming trials (PEITHO, PRAGUE-26, PEERLESS-2, PE-TRACT, and PERSEVERE) that are set to further transform PE care. --- Resources Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement From the American Heart Associationhttps://pubmed.ncbi.nlm.nih.gov/21422387/ Surgical Management and Mechanical Circulatory Support in High-Risk Pulmonary Embolisms: Historical Context, Current Status, and Future Directions: A Scientific Statement From the American Heart Associationhttps://pubmed.ncbi.nlm.nih.gov/36688837/ Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Associationhttps://pubmed.ncbi.nlm.nih.gov/31585051/ Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolismhttps://pubmed.ncbi.nlm.nih.gov/41910345/ PEERLESS II: A Randomized Controlled Trial of Large-Bore Thrombectomy Versus Anticoagulation in Intermediate-Risk Pulmonary Embolismhttps://pubmed.ncbi.nlm.nih.gov/39132600/ Rationale and design of the PE-TRACT trial: A multicenter randomized trial to evaluate catheter-directed therapy for the treatment of intermediate-risk pulmonary embolismhttps://pubmed.ncbi.nlm.nih.gov/39638275/ Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trialhttps://pubmed.ncbi.nlm.nih.gov/34560806/ Design and rationale of the PERSEVERE study: a randomized controlled trial of large-bore mechanical thrombectomy versus the standard of care for high-risk pulmonary embolism https://pubmed.ncbi.nlm.nih.gov/41453591/ Design and rationale of PRAGUE-26: a multicentre, randomised trial of catheter-directed thrombolysis for intermediate-high risk acute pulmonary embolismhttps://pubmed.ncbi.nlm.nih.gov/40464677/ --- BackTable Vascular & Interventional (VI) is the go-to podcast for interventional radiologists, vascular surgeons, and interventional cardiologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

My website My Instagram

"Until immunomodulators, patients [with myeloma] did not have a great overall survival rate. But when we introduced lenalidomide, we started seeing our patients have life expectancies between five and seven years—which was unheard of prior to these immunomodulators going forward. I think it's promising and allows patients to have quality of life versus therapy of life," ONS member Daniel Verina, DNP, RN, ACNP-BC, nurse practitioner for the multiple myeloma program at Mount Sinai Medical Center in New York, NY, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, oncology clinical specialist at ONS, during a conversation about immunomodulators. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 12, 2027. Daniel Verina is on the speakers' bureau for Johnson & Johnson, GlaxoSmithKline, and Pfizer. This financial relationship has been mitigated. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome:  Learners will report an increase in knowledge about the use of immunomodulators to treat cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 401: Multiple Myeloma Treatment Considerations for Oncology Nurses Episode 386: Interprofessional Navigation and the Oral Anticancer Medication Care Compass Episode 290: Cancer Symptom Management Basics: Peripheral Neuropathy ONS Voice articles: Maintain Oral Adherence With ONS Guidelines™ Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations Sexual Considerations for Patients With Cancer Clinical Journal of Oncology Nursing article: Optimizing Transitions of Care in Multiple Myeloma Immunotherapy: Nurse Roles Oncology Nursing Forum articles: Changes in Health-Related Quality of Life During Multiple Myeloma Treatment: A Qualitative Interview Study Facilitators of Multiple Myeloma Treatment: A Qualitative Study ONS book: Multiple Myeloma: A Textbook for Nurses (third edition) ONS Symptom Intervention resource: Peripheral Neuropathy Risk Evaluation and Mitigation Strategies (REMS) Lenalidomide Pomalidomide Thalidomide International Myeloma Foundation: Using Immune Therapy to Fight Multiple Myeloma International Myeloma Society Multiple Myeloma Research Foundation: Treatments for Multiple Myeloma To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We definitely want the diagnosis of multiple myeloma before initiating these drugs. We're going to look at serum protein electrophoresis. We want to make sure that we know the patient has serum free light chains and myeloma proteins to really confirm their disease. Plus, a bone marrow biopsy." TS 7:21 "Each immunomodulator has slightly different side effects. Thalidomide's biggest side effects are constipation, weakness, fatigue, somnolence, peripheral neuropathy, mood swings, hand tremors, and depression. With each generation, less of the side effects actually occurred. Most of lenalidomide's side effects, not discounting the deep vein thrombosis, are pancytopenia—the neutropenia, the anemia, and the thrombocytopenia. [The side effects] are very similar in pomalidomide." TS 15:40 "The REMS program is critical for oral immunomodulator therapies—thalidomide, pomalidomide, and lenalidomide. It was developed due to the risk of developing embryofetal toxicities. ... It is mandatory testing and counseling, so all females of reproductive potential must have two negative pregnancy tests prior to starting the therapy and then monthly pregnancy tests while on the therapy alone. Again, they must use two forms of effective contraceptives or abstain from heterosexual sex four weeks prior, during, and after. And the same thing for men. I focus on that because males may say, 'I have a vasectomy.' These therapies tend to bind to the semen. So, males must still use a latex or synthetic condom during any sexual contact with a female of reproductive potential, even if they did have a vasectomy." TS 18:31 "The capsule itself cannot be chewed, crushed, or opened. I bring that up because as healthcare professionals, we have educated our patients. If it's difficult to swallow capsules or tablets, we've always said to them, 'Oh, don't worry, just crush it into applesauce or open it up and sprinkle it on your mashed potatoes.' But because of this embryofetal toxicity, I advise my patients not to open the capsule. If they can't swallow it for any reason, they have a sore throat or they're just unable to, then [we tell them] to hold the therapy and then call us." TS 22:49 "We spoke about three generations already, but there's actually a fourth generation [of immunomodulators]. They're called cereblon E3 ligase modulators(CELMoDs). They're still in clinical trials but really showing promise in the therapy of myeloma. They're showing very good affinity to cereblons, just like the immunomodulators do. I think, in all cancer therapies, as newer generations come out or newer therapies move forward, some of the older generations might move aside, but they get integrated later on. So I don't think [immunomodulators] will disappear totally, but they will probably be modified." TS 36:39

In this episode, we skip the surface and go straight to the root: the grief, the feminine wound, and the stored resentment that was running her hormones, her weight, and her life.By the end of our call, her HRV jumped to 65 on its own. Her body finally felt safe.If you've done the work and you're still stuck, this one's for you.Support the showHosted by Casey Shipp — 3000+ transformations, Self-Made Millionaire, High Priestess, Writer, Fitness Cover Model, and Founder of the Hotbody App.$30M client wins | $7.8M sold onlineRich isn't rare. Category of one is.

Digital workflows are changing how dentists select, plan, monitor, and communicate clear aligner treatment. In this episode, Kirk Behrendt brings back Dr. Maria Jose Blanco Solis, private practice dentist and clear aligner educator, to discuss how digital workflow innovations are transforming aligner treatment in 2026.You will learn how to evaluate aligner case complexity, monitor tracking and compliance, use auxiliary techniques, manage retention protocols, and think about aligners as part of a broader functional and preventive approach to dentistry. To understand how to make aligner workflows more predictable and practical in your practice, listen to Episode 1059 of The Best Practices Show!Main Takeaways:Clear aligners have expanded from simple aesthetic cases to more complex Class II, Class III, surgical, and multidisciplinary treatment plans.Case selection should include evaluation of occlusion, arch form, profile, crossbites, growth status, recession, and bone support.CBCT, STL files, and complete diagnostic records give doctors better control and confidence when planning aligner treatment.Monitoring appointments should focus on aligner fit, attachment integrity, tracking gaps, programmed IPR, and occlusal contacts.Patient compliance remains essential because aligners generally require 22 hours of daily wear.Auxiliary techniques such as buttons, elastics, TADs, and bootstrap mechanics can improve movement predictability in moderate and severe cases.Retention protocols should account for occlusal stability and patient compliance, especially when deciding between clear retainers and lingual wires.Snippets:00:00 Welcome And Guest Intro02:11 Meet Dr Mari Jose03:14 Aligners In 202605:24 Case Selection Basics06:55 Monitoring And Tracking10:37 Doctor Coaching Support11:13 Micronutrients And Compliance13:03 Retainers And Stability14:45 Aux Techniques And Elastics16:32 Posterior Open Bite Causes18:24 Retainer Wear Schedule19:52 Future Of Aligner Care22:20 Final Tips And Records23:14 Contact Info And Spark24:28 The Exchange Event Preview25:00 Final thoughts on case selection, auxiliary techniques, and live case alignment.Guest Bio/Guest Resources:Dr. Maria Jose Blanco Solis is a dentist in private practice in San Jose, Costa Rica. She has worked with clear aligner therapy through Invisalign and Spark and focuses on digital dentistry, aligner workflow, case selection, clinical monitoring, and doctor education.In this episode, she discusses Spark, Vista aligners, TruGen XR material, one-on-one clinical support, and her upcoming presentation at Smile Exchange on case selection, clinical complexity, auxiliary techniques, and live case review.Resources mentioned:mariajose.blanco@envistaco.comDiscount code for the smile exchange: JOSEBLANCO26https://smilesource.com/exchangeMore Helpful Links for a Better Practice & a Better Life:The Best Practices Show: https://www.actdental.com/podcast/Best Practices Association: https://www.actdental.com/bpaUpcoming Events & Workshops: https://www.actdental.com/events/Smile Source: https://www.smilesource.com/Subscribe on Apple Podcasts: https://podcasts.apple.comSubscribe on Spotify: https://open.spotify.com

Keith finally hits a home run.

What happens after orthodontic treatment ends? For many practices, it's a missed opportunity. Patients lose retainers, stop wearing them, and eventually see their results begin to shift. Meanwhile, practices lose touch with patients and leave recurring revenue on the table. In this episode, Dr. Len Tau sits down with Dr. Blair Feldman, orthodontist, entrepreneur, and co-founder of Retainer Club, to discuss how practices can transform retention from an afterthought into a scalable patient care and revenue strategy. Drawing from his experience building and exiting multiple orthodontic practices, Blair shares how subscription-based retainer programs help practices protect treatment outcomes while creating a seamless patient experience. Dr. Len and Blair explore the economics of retainer programs, patient compliance, recurring revenue opportunities, AI adoption, and the importance of maintaining relationships with patients long after treatment is complete. Whether you're an orthodontist, Invisalign provider, or general dentist offering aligner therapy, this conversation offers practical strategies for extending patient lifetime value while improving clinical outcomes.   What You'll Learn Why retention is one of the most overlooked stages of orthodontic treatment How recurring revenue models can benefit both patients and practices The biggest mistakes practices make after treatment is completed How online retainer fulfillment improves patient compliance Recommended strategies for pricing retainer programs Why patient education is critical for long-term treatment success The role technology and automation play in post-treatment care How practices can increase patient lifetime value through retention programs The importance of transparency when discussing retention and retreatment Business lessons from building and scaling a successful dental startup   Key Takeaways 01:48 Set It and Collect It: How Smart Practices Are Building Recurring Revenue After Aligner Treatments 04:20 The Retainer Gap Most Practices Overlook 08:11 Why Retainers Need Regular Replacement 11:13 Building Predictable Recurring Revenue with Retainer Programs 14:22 The Ideal Retainer Program Playbook 17:36 What Happens When Patients Lose Their Retainers? 18:40 Creating Long-Term Retention and Wellness Scan Strategies 23:05 Subscription Models and Automated Retainer Delivery 24:11 Beyond Orthodontics: Veneer Guards, Whitening Trays, and More 26:30 Why Every Aligner Practice Needs a Retention Program 31:14 Common Objections Practices Have About Retainer Programs 32:35 Lightning Round: Business, Leadership, and Entrepreneurship 38:45 Special Offer for Raving Patients Listeners   — Connect with Dr Blair Co-Founder & President, Retainer Club LinkedIn: Blair Feldman Website: Retainer Club Learn more about how Retainer Club helps practices create recurring revenue while protecting patient outcomes through seamless retainer fulfillment programs.   — Learn proven dental marketing strategies and online reputation management techniques at DrLenTau.com. This podcast is sponsored by Dental Intelligence. Learn more here. This podcast is sponsored by CallRail, call tracking & lead conversion software for dentists. Find out more here. Raving Patients Podcast is your go-to place for the latest and best dental marketing strategies that will help you skyrocket your practice. Follow us for more!

In the UK a panel of vets believes commonly used over the counter flea treatments should be banned because of concern over environmental damage. New Zealand vet Siobhan Graham spoke to Lisa Owen about the situation.

Have you ever wondered whether ARFID is something a person lives with forever? It's one of the most common questions people ask after an ARFID diagnosis, yet the answer is rarely as straightforward as people hope. Adults with ARFID, parents of children with ARFID, and even clinicians often want to know what recovery really looks like, whether meaningful change is possible, and how neurodivergence influences the long-term course of Avoidant Restrictive Food Intake Disorder. In this episode of Dr. Marianne-Land, Dr. Marianne Miller explores the question, "Is ARFID lifelong?" through a neurodivergent-affirming, trauma-informed lens. She examines how conversations about ARFID recovery often become oversimplified and why many people focus on the wrong markers when trying to determine whether treatment is working. The discussion moves beyond food variety alone and considers broader questions about quality of life, flexibility, self-understanding, sensory processing, and participation in meaningful life experiences. Is ARFID Lifelong? Many people assume there are only two possible outcomes: either ARFID completely disappears or nothing changes. The reality is often far more nuanced. Dr. Marianne discusses why the future cannot be predicted by a diagnosis alone and how growth, adaptation, treatment, accommodations, and self-understanding can shape a person's relationship with food over time. What Does ARFID Recovery Look Like? Recovery from ARFID does not always fit traditional eating disorder narratives. In this episode, Dr. Marianne explores how recovery may involve reduced distress around food, increased flexibility, improved nutrition, greater participation in social experiences, and less time spent managing food-related anxiety. She also examines why quality of life deserves a central place in conversations about recovery. ARFID, Autism, ADHD, and Neurodivergence ARFID frequently overlaps with autism, ADHD, sensory processing differences, OCD, anxiety, chronic illness, and other neurodivergent experiences. Understanding these intersections can dramatically change how people view treatment, accommodations, and long-term outcomes. Dr. Marianne discusses why neurodivergent-affirming care matters and why recovery may look different from person to person. Why the Question Matters For many people, the question "Is ARFID lifelong?" is not simply about food. It is often about identity, hope, relationships, travel, family experiences, social connection, and the desire to spend less mental energy managing meals. Dr. Marianne explores the emotional weight behind this question and why understanding the future can feel so important after years of struggle. In This Episode, You'll Learn You'll learn why ARFID recovery is rarely a simple yes-or-no answer, how sensory processing and neurodivergence influence treatment outcomes, why quality of life matters alongside food variety, and how people can experience meaningful growth even when challenges remain. You'll also gain a deeper understanding of why conversations about ARFID often benefit from curiosity, flexibility, and a broader definition of recovery. Related Episodes When Safe Foods Stop Working: ARFID Plateaus, Burnout, & What Helps on Apple & Spotify. ARFID Explained: What It Feels Like, Why It's Misunderstood, & What Helps on Apple & Spotify. Why Sensory-Attuned Care Matters More Than Exposure in ARFID Treatment on Apple & Spotify. Complexities of Treating ARFID: How a Neurodivergent-Affirming, Sensory-Attuned Approach Works on Apple & Spotify. Learn More About ARFID If you're looking for neurodivergent-affirming support for ARFID and selective eating, check out Dr. Marianne Miller's self-paced ARFID & Selective Eating Course. Designed for adults with ARFID, parents, caregivers, and providers, the course explores sensory processing, nervous system regulation, autism, ADHD, family dynamics, food flexibility, accommodations, and practical strategies that move beyond shame, pressure, and one-size-fits-all approaches. Learn more at: https://www.drmariannemiller.com/arfid About Dr. Marianne Miller Dr. Marianne Miller is a licensed marriage and family therapist, eating disorder therapist, and host of the Dr. Marianne-Land podcast. She specializes in ARFID, binge eating disorder, anorexia, bulimia, and neurodivergent-affirming eating disorder care. Dr. Marianne developed the Neurodivergent-Affirming Integrative Therapy for ARFID (NAIT-AR) framework and provides therapy, coaching, courses, and educational resources for individuals, families, and professionals. Website: https://www.drmariannemiller.com Instagram: @drmariannemiller

Perimenopause: Is It Perimenopause… or Am I Just Going Crazy? Mood swings. Brain fog. Anxiety. Sleepless nights. Hot flashes. Suddenly forgetting why you walked into a room. If you've ever wondered, "Is this perimenopause, or am I just losing my mind?"—this episode is for you. In this candid and informative episode of MamaDoc BabyDoc, Dr. Renda Knapp tackles the often misunderstood transition of perimenopause. She will break down what perimenopause actually is, why symptoms can start years before menopause, and how fluctuating hormones can affect everything from your mood and memory to your sleep and overall well-being. You'll learn: Common signs and symptoms of perimenopause Why symptoms can be so unpredictable What's normal—and when to seek medical advice Treatment options, including hormone therapy and lifestyle changes How to advocate for yourself when you feel like something isn't right Whether you're experiencing symptoms yourself or supporting someone who is, this episode will help you understand what's happening and remind you that you're not alone—and you're definitely not crazy

Should you purge after a lymphatic drainage treatment?Short answer: no.I'm Jen Wilson, The Healing Rebel, and this episode is me getting into why the "go hard or go home" mentality has crept into lymphatic drainage, why some practitioners are pushing aggressive treatments designed to make you purge afterwards, and why that's the opposite of what your body actually needs to heal.This episode came out of a conversation with a fellow massage therapist friend whose client kept going to someone else for lymphatic drainage because she always had a big purge afterwards. My reaction was: no. That's not what's meant to happen.What I cover:What purging actually is and when it's appropriate (sickness, diarrhoea, your body clearing something genuinely harmful)Why a treatment that makes you purge is too aggressive for your nervous systemThe concept of a "healing crisis" and why it's a red flag, not a badge of honourHow the parasympathetic nervous system safety is where healing actually happensThe Vodder technique I was trained in, and how a proper, gentle lymphatic drainage treatment worksWhy the dramatic before-and-after photos of lymphatic drainage are mostly fluid loss that comes straight backWhy getting lymphatic drainage before your holiday won't keep you looking sculpted on the beachWhat aggressive treatments actually cost you (vitamins, minerals, microbiome)Why being soothed during a treatment matters more than the manual technique itselfHow to support your lymphatic system at home in as little as one minute a dayA few questions I answer:Should you purge after lymphatic drainage?What is a healing crisis, and is it real?Why does my body purge after some treatments?Is aggressive lymphatic drainage better than gentle?Can I do lymphatic drainage on myself?Does lymphatic drainage help you look thinner?Free download: my Lymphatic Drainage Self-Care Routine. A gentle, guided way to support your lymphatic system every day, in as little as a minute. https://iamjenwilson.thrivecart.com/lymph/If you're in or around Glasgow and you'd like to come in for a proper, gentle Manual Lymphatic Drainage treatment, all the booking details are over at www.iamjenwilson.comGet my book 9 Rules to Sort Your Shit here - https://amzn.to/4eYtVnqRebel and Divine Anarchist hoodies and t-shirts here https://iamjenwilson-2.teemill.com/collection/new/Gut Friendly, Easy Recipe book here https://amzn.to/4gJsGICFollow my social channelsSubscribe to my YouTube Channel https://www.youtube.com/iamjenwilsonLike my Facebook page https://www.facebook.com/IamJenWilsonFollow me on Instagram https://instagram.com/iam.jenwilson

What if a cancerous tumour could be destroyed without a single incision, stitch or scar? A Singapore grandfather waiting for a liver transplant has become one of the first patients in Southeast Asia to undergo a breakthrough treatment called histotripsy - a technology that uses focused sound waves to destroy a liver tumour. Could this be a glimpse into the future of medicine, where cancer treatment becomes less invasive? Hosted by Michelle Martin, this episode explores the science, the human story and what innovations like histotripsy could mean for longevity and the future of cancer care. Send this episode onto someone who needs a boost of hope. Guest: Prof Brian Goh, Head of Department of Hepato-pancreato-biliary and Transplant Surgery, SGH & NCCS, and Principal Investigator of the HALT Study.See omnystudio.com/listener for privacy information.

We're dropping this bonus episode because something genuinely historic happened in oncology and we couldn't wait until our regular schedule to talk about it. Dr. Mark Lewis, GI medical oncologist, pancreatic cancer survivor, and one of our absolute favorite guests. He just got back from ASCO, the Super Bowl of oncology, where a new drug called daraxonrasib received one of only about six standing ovations in the conference's history, including applause that broke out mid-sentence when researchers showed the survival data on-screen. The drug targets a mutation that drives the vast majority of pancreatic cancer and has been considered "undruggable" for decades and it works not by attacking the mutation directly, but by cutting off the downstream signals it sends, like snipping the wire instead of fighting with the switch. The results are remarkable. In patients who had already received standard chemotherapy, daraxonrasib roughly doubled survival time and delivered it in pill form rather than an IV every two weeks, a meaningful quality-of-life difference for people who are already facing the hardest year of their lives. Mark walks us through the science, the side effects (rash, because RAS proteins live in skin too), the path to FDA approval, and what this means beyond pancreatic cancer, the same KRAS mutations show up in about 30% of lung cancers and 40% of colon cancers. Takeaways: Pancreatic cancer has been devastatingly hard to treat, 85% of patients are incurable at diagnosis because it spreads silently and there's no good screening, leaving most patients with a median survival of about a year on IV chemotherapy. KRAS, the mutation driving nearly all pancreatic cancer, was long considered "undruggable", the protein was so smooth and spherical that no drug could bind to it, and researchers were actively discouraged from pursuing it as a target. Daraxonrasib works by cutting the power rather than fighting the switch, instead of binding to the KRAS protein itself, it uses molecular glue to interrupt the downstream growth signals the mutation sends, an approach that took decades to develop and wasn't taken seriously until now. The trial results roughly doubled survival and the treatment is a daily pill, not an IV, patients who had already been treated with chemotherapy gained approximately an additional year of life with improved quality of life, which represents one of the most significant advances in pancreatic cancer treatment in decades. This breakthrough has implications far beyond the pancreas, KRAS mutations drive about 30% of lung cancers and 40% of colon cancers too, and proving the target is druggable opens the door to a new generation of treatments across multiple cancer types. Want more Dr. Mark Lewis? X: @marklewismd To Get Tickets to Wife & Death: You can visit Glaucomflecken.com/live  We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! –⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://www.patreon.com/glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Also, be sure to check out the newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://glaucomflecken.com/glauc-to-me/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you are interested in buying a book from one of our guests, check them all out here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.amazon.com/shop/dr.glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you want more information on models I use: Anatomy Warehouse provides for the best, crafting custom anatomical products, medical simulation kits and presentation models that create a lasting educational impact.  For more information go to Anatomy Warehouse DOT com. Link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://anatomywarehouse.com/?aff=14⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Plus for 15% off use code: Glaucomflecken15 -- A friendly reminder from the G's and Tarsus: If you want to learn more about Demodex Blepharitis, making an appointment with your eye doctor for an eyelid exam can help you know for sure. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.EyelidCheck.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for more information.  Produced by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Human Content⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Today's podcast is a natural follow up to our podcasts on Slow Codes and Unilateral DNR orders.Today we talk about a new study about how clinicians talk about potentially non-beneficial life-prolonging treatments, published in JAMA Network Open. Do they adhere to society guidelines, which allow as permissible approaches only shared decision-making and following institutional policy.  Or do they take alternative approaches, like not offering interventions, not mentioning interventions, or simply stating a plan to limit interventions? Turns out doctors are using these alternative approaches frequently. Our guests are Jason Batten, Liz Dzeng, and Teva Brender, all clinicians, all of whom have been thinking about and wrestling with the ethical reasoning behind these approaches. We all admit to using these approaches.  Are the alternative approaches wicked games (song hint), and our response should be to stop these behaviors, beginning with ourselves? After all, if you ask patients or surrogates, they're likely to say they want all the options and may not universally welcome recommendations.  Or, as with slow codes, does the fact that these alternative approaches are in common use suggest that the guidelines should be revised?  You listen and decide! -Alex Smith   Additional links: Dzeng 2023 JAMA IM: The larger ethnographic study from which data was drawn with data drawn from high- medium- and low-intensity hospitals. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2806959 Brender 2025 JAMA NO: Factors that exacerbate or mitigate moral distress related to potentially non-beneficial treatments.https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2835316 Dzeng 2015 JAMA IM: Study illustrating that more senior physicians feel more comfortable not offering or recommending against futile CPR. Relevant quote: "Experienced physicians at all sites generally were comfortable engaging in best interest decision making and, when clinically appropriate, not offering or making explicit recommendations against offering resuscitation." https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2212265 Weiss Goitiandia AJOB 2025: Reasons why some clinicians would hesitate to go to the ethics committee / futility process for these discussions: https://www.tandfonline.com/doi/10.1080/15265161.2025.2457734?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Axelrod AJOB 2025: Discusses some of the systemic consequences of using physiologic futility as a standard and how it might contribute to a healthcare system that imposes aggressive treatments on vulnerable patients. https://www.tandfonline.com/doi/full/10.1080/15265161.2025.2530715#d1e152  

A daily pill can double survival time in patients with the world's deadliest cancer, according to the results of a clinical trial that experts are saying is a gamechanger and one of the biggest breakthroughs in decades. To find out more about how daraxonrasib works and how life-changing it could be for patients, Madeleine Finlay speaks to Prof Naureen Starling, consultant medical oncologist at the Royal Marsden hospital. Help support our independent journalism at theguardian.com/sciencepod

Send me a derm question or story through text or voicemail!Can cats safely take Apoquel or Zenrelia? In this episode, we take a deep dive into the use of JAK inhibitors in feline dermatology, exploring the science behind atopic disease, practical treatment considerations, and the realities of off-label medication use in cats.Watch The Episode: https://www.youtube.com/@thedermvet3932Follow The Derm Vet Podcast: https://www.instagram.com/thedermvetpod/Follow Me: https://www.instagram.com/thedermvet/Timestamps00:00 Intro01:31 Itch Inquiry: Atopic Dogs and the pathophysiology04:22 JAK Inhibitors and Cats05:58 Using Apoquel with a Cat 08:58 Using Zenrelia with a Cat10:53 Dosing These Medications in Cats 12:35 Lab Work Monitoring the Cats14:02 The Risk14:25 The Duration15:40 Discussion of Off Label Use with Owners16:58 Outro

Politics, activism, and a little weird science — this episode has it all. We're joined by Tabria Majors, model and activist, for a real conversation about systemic challenges, navigating the internet as a Black woman, and the state of our democracy. Then we zoom out and touch on AI, media censorship, racial bias in the justice system, and the scientific discoveries that just aren't needed. TIMESTAMPS 0:00 - Michael Movie, Dutton Ranch & Scary Movie 6 4:17 - Intro 5:06 - The ladies Introduce Tabria Majors 7:50 - The Struggles Behind a Black Influencer 10:31 - The Knicks Lost to the Spurs, It's Trump's Fault 12:53 - Leftist Politics Online Are Dangerous When There Is No Call to Action 15:40 - How Tabria Got Her Start in Political Activism 27:36 - How Voter Guides Can Help Inform 38:13 - The Treatment of Black Women in Politics 49:15 - Scott Pelley Fired from 60 Minutes 58:11 - Karmelo Anthony (teen) Gets Found Guilty for Murder 1:05:00 - Stanford Study Shows on AI Hiring Practices 1:17:56 - Scientists Eat Sourdough Bread Made from Dead Mummy's Remains 1:23:50 - Wrapping Up w/ Tabria 1:25:20 - End of Show/ Corny Joke -------------------------------------------------------------------- Please be sure to follow us on all our social media: Cashapp: $Headwrappod Bluesky: @headwrappod Instagram: @headwrapsandlipsticks TikTok: @headwrapsandlipsticks Facebook: Headwraps And Lipsticks: The Podcast Website: www.headwrapsandlipstick.com Email: hosts@headwrapsandlipsticks.com

What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology, Dr. Kelly Bree, Dr. Saum Ghodoussipour, and Meredith Donahue, N.P., join host Dr. Vignesh Packiam to discuss the power of shared decision-making across the NMIBC spectrum. They explore risk-adapted treatment selection, when to escalate or de-escalate therapy, and how to navigate conversations about recurrence risk, treatment burden, quality of life, and the possibility of cystectomy. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by an educational grant from Johnson & Johnson. --- Timestamps 00:00 - Introduction01:55 - Second Opinions and Patient Counseling06:08 - Intermediate Risk Stratification12:13 - Treatment Options for Intermediate Risk NMIBC16:20 - BCG and Alternative Treatments for High Risk NMIBC26:49 - Options for BCG-Unresponsive NMIBC31:42 - Sequencing and Cystectomy37:03 - Financial and Time Toxicity41:08 - Biomarkers and ctDNA44:04 - Future Trials and NMIBC Innovations --- More about this episode They also review emerging therapies such as ZUSDURI, the evolving role of intravesical treatments, and the promise of biomarkers and ctDNA for personalized care. The discussion covers practical strategies for patient counseling, key updates to clinical guidelines, and a preview of innovations shaping the future of NMIBC management. --- Resources Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial:https://pubmed.ncbi.nlm.nih.gov/41571573/ Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non–Muscle-Invasive Bladder Cancerhttps://ascopubs.org/doi/10.1200/JCO-25-01324 CIRCULATING TUMOR DNA AS A BIOMARKER FOR UPSTAGING AND ADVERSE PATHOLOGY IN HIGH-RISK NON–MUSCLE-INVASIVE BLADDER CANCER:https://www.auajournals.org/doi/abs/10.1097/01.JU.0001191388.74345.c9.09 Preoperative Circulating Tumor DNA Predicts Upstaging and Recurrence in High-Risk Nonmuscle-Invasive Bladder Cancer Undergoing Radical Cystectomyhttps://pubmed.ncbi.nlm.nih.gov/41843048/ --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

This episode of the PeerDirect Medical News Podcast reviews three developments with potential implications across nephrology, oncology, and public health. Highlights include the FIND-CKD trial showing finerenone may slow disease progression in chronic kidney disease patients without diabetes, seven-year CROWN trial data demonstrating durable long-term disease control with lorlatinib in advanced ALK-positive lung cancer, and a JAMA Network Open study linking measles-related vitamin A misinformation to increased toxic exposures. Together, these findings underscore evolving treatment paradigms and the growing impact of health communication on patient outcomes.

In this episode of The Lead, host Christopher C. Cheung, MD, MPH, FHRS, is joined by Edward P. Gerstenfeld, MD, MS, FHRS, and Paul C. Zei, MD, PhD, FHRS, to discuss the journal article, A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation versus Anti-Arrhythmic Drug Therapy as a First Line Treatment for Persistent Atrial Fibrillation (AVANT GUARD). Together, they review the study design and findings, examining pulsed field ablation and anti-arrhythmic drug therapy as first-line treatment approaches for patients with persistent atrial fibrillation. Learning Objectives Review the design and key findings of the AVANT GUARD study comparing pulsed field ablation with anti-arrhythmic drug therapy as first-line treatment for persistent atrial fibrillation. Discuss the potential role of pulsed field ablation as an initial treatment strategy for patients with persistent atrial fibrillation. Examine the comparative considerations of ablation-based and pharmacologic approaches in the management of persistent atrial fibrillation.   Podcast Contributors: Host: Christopher C Cheung, MD, MPH, FHRS       Guests: Edward P. Gerstenfeld, MD, MS, FHRS and Paul C Zei, MD, PhD, FHRS   Disclosures: Christopher C Cheung, MD, MPH, FHRS Honoraria/Speaking/Consulting Fee: Medtronic, Inc., Biotronik, Biosense Webster, Inc., Abbott Edward P. Gerstenfeld, MD, MS, FHRS Honoraria/Speaking/Consulting Fee: Medtronic, Inc., Biosense Webster, Inc., Abbott, Boston Scientific, Varian Medical Systems Other Non-Financial Relationships: Adagio Medical, Boston Scientific, Abbott Medical Research: Abbott Medical Officer, Trustee, Director, Committee Chair, or Other Fiduciary Role: American College of Cardiology Paul C Zei, MD, PhD, FHRS Honoraria/Speaking/Consulting Fee/Speaker's Bureau: Varian Medical Systems, Biosense Webster, Inc., Abbott, Boston Scientific, APT Medical Research: Biosense Webster, Inc.

Sign up for Dr Matt's FREE substack:https://substack.com/@connectiondocs Join Chef AJ's Exclusive Plant-Based Community. Become part of the inner circle and start simplifying plant-based living - with easy recipes and expert health guidance. Find out more by visiting: https://community.chefaj.com/ ORDER MY NEW BOOK SWEET INDULGENCE!!! https://www.amazon.com/Chef-AJs-Sweet-Indulgence-Guilt-Free/dp/1570674248 GET MY FREE INSTANT POT COOKBOOK: https://www.chefaj.com/instant-pot-download Disclaimer: This podcast does not provide medical advice. The content of this podcast is provided for informational or educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health issue without consulting your doctor. Always seek medical advice before making any lifestyle changes. To book a consultation with Matt: https://form.jotform.com/241997228318164 Matthew Lederman, MD, is a board-certified Internal Medicine Physician and a pioneering thought leader in holistic health. Renowned for his innovative integration of plant-based nutrition, Nonviolent Communication (NVC), trauma-informed care, and lifestyle medicine, Dr. Lederman's work highlights the profound interconnectedness of physical, emotional, and relational well-being. As a certified Nonviolent Communication Trainer through the Center for Nonviolent Communication (CNVC), Dr. Lederman combines Polyvagal Theory, Somatic Awareness Principles, and Pain Reprocessing to empower individuals to heal from within. His approach helps people address the root causes of chronic health challenges, fostering emotional resilience and cultivating meaningful connections. Email:Support@ConnectionDocs.com Website: https://www.connectiondocs.com/ Free Resources (includes Feelings & Needs Sheet for children AND Role-Play Video “Talking to Your Child About ‘Too Much' Device Time”) : https://www.connectiondocs.com/resources Substack (Weekly Articles on Connection): https://substack.com/@connectiondocs Breath & Body Regulation Training Tool: https://webekalm.com/ webe Pärents Podcast https://webekalm.com/pages/webeparents AI Connection Coach:https://app.kinectin.com/signup Main Book WELLNESS TO WONDERFUL: 9 Pillars for Living Healthier, Longer, and with Greater Joy: https://www.amazon.com/dp/B0C2S1JGZK?ref=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&ref_=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&social_share=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&starsLeft=1&skipTwisterOG=1&bestFormat=true Children's E-Books (Supporting Children Bringing More Connection Into Their Lives): Healing Shame and Connecting to Self-Worth and Intrinsic Value: https://webekalm.com/products/lily-and-her-beautiful-flower Being Honest with Care https://webekalm.com/products/ella-and-the-two-gifts-ebook Supporting Children During Emergencies (fires, earthquakes, etc):'https://webekalm.com/products/brave-hearts-facing-the-fire-ebook Social Media: Instagram: https://www.instagram.com/TheConnectionDocs Substack Newsletter: https://connectionDocs.substack.com Facebook: https://www.facebook.com/connectionDocs X: https://x.com/connectionDocs

This episode covers: Cardiology This Week: A concise summary of recent studies Transcatheter treatment of tricuspid regurgitation Carcinoid heart disease Milestones: MADIT-II Trial Host: Wilfried Mullens Guests: Stephan Baldus, Heidi Connolly and Konstantinos Koskinas Want to watch that episode? Go to: https://esc365.escardio.org/event/2560 Want to watch that extended interview on transcatheter treatment of tricuspid regurgitation, go to: https://esc365.escardio.org/event/2560?resource=interview   Disclaimer  ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Heidi Connolly, Nicolle Kraenkel and Wilfried Mullens have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. Stephan Baldus has declared to have potential conflicts of interest to report: research grant from Abbott, lecture fees from Abbott and Edwards. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Wilfried Mullens Guest: Stephan Baldus Want to watch that extended interview, go to: https://esc365.escardio.org/event/2560?resource=interview Want to watch that entire episode? Go to: https://esc365.escardio.org/event/2560   Disclaimer ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel and Wilfried Mullens have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. Stephan Baldus has declared to have potential conflicts of interest to report: research grant from Abbott, lecture fees from Abbott and Edwards. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Send us Fan MailYou can build the best peer support team on paper, fund the best wellness initiatives, and still miss the people who are hurting the most. That's where this conversation with Dr. Stacey Raymond goes, and we don't stay polite about it. We talk about why first responder mental health needs to start at the academy level, with a clear warning: the job will expose you to traumatic events, and it will change your sleep, your relationships, and how you see the world. We also get specific about a topic that frustrates a lot of officers and clinicians alike: what “vetted therapist” should actually mean. If you're a clinician who wants to work with police, fire, EMS, or dispatch, cultural competence isn't a buzzword. It's ride-alongs, learning how calls really flow, understanding why police often don't get to process between calls, and recognizing how trust is earned minute by minute. Along the way we highlight the hidden load carried by 911 dispatchers, including relentless exposure to crisis audio, limited movement, and little closure due to HIPAA. Then we zoom out to leadership and risk. Chiefs and supervisors often want certainty about who is “safe,” but human behavior is dynamic and can shift fast with substances, gambling addiction, and life stress. Dr. Raymond shares research using the ACEs questionnaire and adult attachment patterns, showing how certain adverse childhood experiences correlate with avoidant, mistrustful coping, meaning some officers will bypass peer support and refuse therapy even when they know they're struggling. If you care about police wellness, first responder resilience, EMDR-informed trauma treatment, and building a culture where getting help doesn't feel dangerous, hit play. Subscribe, share this with someone in public safety, and leave a review so more people can find the conversation.To reach Stacy, please go to her website: https://www.drstacyraymond.com/Her Instagram is https://www.instagram.com/stacyshrink1414/You can buy her book hereDeemedFit: First Responder OwnedWe are a first responder owned company looking to get first responders in the best mental shape.Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showYouTube Channel For The Podcast

For the first time in decades, US officials confirmed new cases of the New World screwworm: a flesh-eating parasite that eats living tissue from the inside out and can cross over to humans. As the government prepares emergency declarations and a $750 million fly factory in Texas, McCullough Foundation epidemiologist Nicolas Hulscher reveals the not-so-surprising, over-the-counter medication that he says “provided more than 97% protection against screwworm infestations in wounds under real-world conditions.” But because it's so cheap and easily available, you will likely never hear about it in the headlines. In this special episode hosted by Dr. Kelly Victory, Nic Hulscher discusses the New World screwworm, ebola, and breaks down the meteoric rise of alpha-gal syndrome (meat allergies) and its connections to bio-engineered ticks. Nicolas Hulscher is an epidemiologist and administrator at the McCullough Foundation. He earned a Master of Public Health degree with a specialization in epidemiology at Michigan School of Public Health. He has contributed to the publication of more than 25 scientific studies, advancing understanding of COVID-19 vaccine injuries, childhood vaccine injuries, cancer treatments, SARS-CoV-2, and H5N1 avian influenza. Follow at https://x.com/NicHulscher Dr. Kelly Victory is Chief of Emergency & Disaster Medicine at The Wellness Company. A trauma and emergency specialist with over 30 years of experience, she served as Chief Medical Officer for Fortune 500 companies and is an alumna of Harvard's National Preparedness Leadership Initiative. She is a contributing author of “Toxic Shot: Facing the Dangers of the COVID Vaccines.” Find more at https://x.com/DrKellyVictory 「 SUPPORT OUR SPONSORS 」 • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/fatty15⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/paleovalley⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twc.health/drew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Susan Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/firstladyoflove⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Content Producer • Emily Barsh - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/emilytvproducer⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

06 10 26 Wheat Heading Treatments by Ag PhD

Migraines are often dismissed as “just a bad headache,” but they can be much more serious and disruptive. So what actually causes migraines, and when should someone stop trying to push through the pain?In this episode of Baptist Health Talk, host Sandra Peebles speaks with Dr. Maria Vera Silva, neurologist at Baptist Health Miami Neuroscience Institute, and Dr. Andrew Forster, internal medicine physician at Baptist Health Primary Care, about what migraines are, how they affect the brain, and why treatment is not one size fits all.In this conversation, they discuss: Why migraines are considered a neurologic disease  How migraines differ from regular headaches  Common triggers, including stress, hormones, sleep changes, foods and weather  The connection between migraines and mental health  Treatment options, including anti inflammatories, triptans, CGRP inhibitors and Botox  What to know about viral migraine “hacks” on social media  When migraine symptoms should prompt a visit to a doctor Migraines can interfere with work, school, family life and everyday activities. Understanding the signs, triggers and treatment options can help patients get the right care sooner.For more health and wellness information, visit Baptist Health South Florida's resource blog: baptisthealth.net/newsHost:Sandra PeeblesAward-Winning JournalistGuest:Maria Andreina Vera Silva, M.D. NeurologistBaptist Health Miami Neuroscience InstituteAndrew Forster, M.D. Internal Medicine Physician Baptist Health Primary CareIf you found this episode helpful, you may also enjoy:A 'Heads Up' on Migraine & Headache Disorders

What a privilege, introducing Device Nation to Aaron Lepper, BONESUPPORT US VP of Sales!CERAMENT G is a product we believe you should consider for YOUR bag, as it's the first and only injectable antibiotic-eluting bone graft indicated for use in the management of bone infection.-Remodels into host bone in 6-12 months (1)-Injectable and flowable-Gentamicin elution above MIC that's reliable and consistent (2)-High local concentration of gentamicin, without high serum gentamicin levels (2)Checks off a lot of boxes, check it out!Contact Aaron Lepper here: aaron.lepper@bonesupport.comLearn more here: https://www.bonesupport.com/en-us/products/cerament-g/What's in YOUR bag?1. Ferguson et al. ‘Radiographic and Histological Analysis of a Synthetic Bone Graft Substitute Eluting Gentamicin in the Treatment of ChronicOsteomyelitis'. J. Bone Joint Infect. 2019; 4(2): 76-84.2. Stravinskas et al. Pharmacokinetics of gentamicin eluted from a regenerating bone graft substitute - In vitro and clinical release studies. BoneJoint Res. 2016 ;5 :427-35Support the show

| S03 E22 | On the cusp of the 10th anniversary of MAiD in Canada, and as our country prepares to expand Medical Assistance in Dying (MAID) to cases where mental illness is the sole underlying condition, important questions remain about safeguards, mental health care, physician conscience rights, and the protection of vulnerable people. In this final episode of Season 3, Deacon Eric Gurash and Dr. Brett Salkeld welcome Larry Worthen of the Christian Medical and Dental Association of Canada for a conversation about the future of MAID, the challenges facing patients and physicians, and the Christian call to accompany those who suffer with dignity, compassion, and hope. 00:00 Welcome and Guest Intro 01:02 Tour Stories 02:40 MAID Expansion Explained 05:26 Legal Origins and Slippery Slope 09:03 Burden and Human Dignity 11:00 From Burden to Infanticide 15:08 Conscience Rights and Doctor Duties 17:24 MAID as "Treatment" 18:30 Real Cases and Warnings 20:09 Safeguards Always Fail 22:09 Normalize Suicide Agenda 23:34 Doctor Shopping Loopholes 24:51 Keanu Case Explained 26:57 Care Wait Times Crisis 28:24 Palliative Care Underserved 30:13 Suicide Line After Expansion 33:54 Church Response 39:11 Dying Well 42:40 Final Blessing Farewell

Iran's latest strategy, Qatar's spending in the U.S., miscarriage treatment in pro-life states, and a fleet of traveling museums. Plus, Cal Thomas on public confidence in the news media, a Bangladeshi buffalo, and the Tuesday morning newsSupport The World and Everything in It today at wng.org/donateAdditional support comes from Ascend by Unbound. A real-world, faith-centered college alternative for gap-year, trades, and degree-seeking students. More at beunbound.us/worldfrom WatersEdge. Where faithful investments strengthen ministry. 4.6% APY on a 15-month term. WatersEdge.com/invest WatersEdge securities are subject to certain risk factors as described in our Offering Circular and are not FDIC or SIPC insured. This is not an offer to sell or solicit securities. WatersEdge offers and sells securities only where authorized; this offering is made solely by our Offering Circular.And from St. Dunstan's, inviting young men into the building arts and the adventure of holiness on a Blue Ridge Mountains farm... stdunstansacademy.org

You can’t think your way out of OCD In part one of our three-part series on Anxiety and OCD, Dr. Jon Abramowitz helps us understand why intrusive thoughts are normal, how OCD turns them into a source of distress, and what keeps the cycle going. We explore uncertainty, reassurance-seeking, relationship dynamics, and the research-backed treatments that help people reclaim their lives from OCD.In this conversation, we unpack the surprising truth about intrusive thoughts, why reassurance often backfires, and how learning to tolerate uncertainty can be a powerful path toward recovery. “There is no such thing as absolute certainty.” – Dr. Jon Abramowitz Time Stamps for Why Certainty Isn’t the Answer: OCD, Intrusive Thoughts & Recovery with Dr. Jon Abramowitz (301) 02:40 Understanding anxiety and its disorders 05:46 Distinguishing normal anxiety from OCD 08:21 The nature of obsessional thoughts 14:09 The cycle of OCD and compulsions 16:53 The role of exposure and response prevention 19:44 Understanding scrupulosity in OCD 25:25 Treatment approaches for OCD 33:34 Managing distress in OCD therapy 36:55 Understanding control and uncertainty in OCD 40:41 Distinguishing OCD from Obsessive-Compulsive Personality Disorder 50:02 Supporting loved ones with OCD About our Guest – Dr. Jon Abramowitz (301) Jonathan (Jon) Abramowitz, Ph.D., is Professor and Director of Clinical Training in the Department of Psychology and Neuroscience at the University of North Carolina at Chapel Hill. His research and clinical work focuses on obsessive-compulsive disorder (OCD) and anxiety disorders, including fears and phobias, health anxiety, and panic attacks. He has authored over 350 scientific publications and 20 books, which have been translated into several languages. He served as President of the Association for Behavioral and Cognitive Therapies and as Editor or Associate Editor of several academic journals. Dr. Abramowitz has received wide recognition for his scholarly work and contributions.   Resources for Why Certainty Isn’t the Answer: OCD, Intrusive Thoughts & Recovery with Dr. Jon Abramowitz (301) Dr. Abramowitz website – Resources and information OCD resources for clinicians and consumers  Beyond Attachment Styles course is available NOW!   Learn how your nervous system, your mind, and your relationships work together in a fascinating dance, shaping who you are and how you connect with others. Online, Self-Paced, Asynchronous Learning with Quarterly Live Q&A’s! Earn 6 Continuing Education Credits – Available at Checkout As a listener of this podcast, use code BAS15 for a limited-time discount.       You are invited!  Join our exclusive community to get early access and discounts to things we produce, plus an ad-free, private feed. In addition, receive exclusive episodes recorded just for you. Sign up for our premium Neuronerd plan!! Click here!!    Get your copy of Secure Relating here!!

What if your chronic pain, migraines, anxiety, fatigue, IBS, or other persistent symptoms aren't permanent at all? In this fascinating conversation, Dr. Mariza sits down with Dr. Howard Schubiner, physician, researcher, and leading expert in neuroplastic symptoms, to explore a groundbreaking approach that is helping people reverse chronic pain and other conditions long considered lifelong and irreversible. Dr. Schubiner explains how the brain creates pain as a protective danger signal, why emotional injuries can activate the same neural pathways as physical injuries, and how unresolved trauma, chronic stress, adverse childhood experiences, and self-silencing can contribute to chronic symptoms years or even decades later. Together, they discuss the growing body of research around neuroplastic pain, the connection between emotions and physical symptoms, and why many people continue suffering despite normal scans, medications, and conventional treatments. Dr. Mariza also shares her own experience with chronic migraines, leading to a powerful live demonstration of how pain reprocessing techniques can begin shifting the brain's expectations and neural patterns in real time. This conversation offers hope for anyone who has been told they simply need to manage their symptoms for the rest of their life. HOWARD SCHUBINER Dr. Howard Schubiner is a physician, researcher, educator, and one of the leading voices in the field of neuroplastic symptoms. He is the author of Unlearn Your Pain and has spent decades helping patients recover from chronic pain, migraines, fibromyalgia, IBS, anxiety, chronic fatigue, and other conditions through evidence-based approaches rooted in neuroscience, emotional processing, and neuroplasticity. IN THIS EPISODE What neuroplastic symptoms are and why they are often misunderstood How childhood experiences, trauma, and chronic stress can contribute to chronic pain Why migraines, IBS, fibromyalgia, anxiety, and fatigue may share similar brain-based mechanisms The powerful connection between emotions and physical symptoms How pain reprocessing therapy helps retrain the brain's danger signals Why self-silencing and people-pleasing often show up in women with chronic symptoms The role of emotional awareness and expression in healing A live demonstration of changing neural pathways through visualization and safety signals QUOTES“Pain can be a message that our brain sends.” “Emotional injury causes the same parts of the brain to light up as physical injury.” “Chronic pain is not necessarily a life sentence.” RESOURCES MENTIONED Use code ENERGIZED and get 30% off on your first BATCH order http://hellobatch.com/ENERGIZED Get your copy of Dr. Howard Schubiner Newest Book now https://www.amazon.com/Unlearn-Your-Pain-Recovering-Depression/ Unlearn Your Pain Website The Association for the Treatment of Neuroplastic Symptoms (ATNS) Howard Schubiner Instagram Howard Schubiner Facebook RELATED EPISODES  751: Bloating, Brain Fog & Hormone Chaos? Your Gut May Be the Root Cause with Dr. Cassie Smith 743: Why Your Heart Risk Changes in Menopause (And What You Can Do About It) with Dr. Jayne Morgan 717: “I Don't Feel Like Myself Anymore”: The Mental & Emotional Reality of Perimenopause 741: Estrogen, Gut Health, Mitochondria, and Cardiovascular Health: What Changes In Perimenopause with Dr. Siobhan Mitchel

Trump just stormed off the “Meet the Press” set after going nuclear on Kristen Welker and NBC's nonstop 2020 election lies. You HAVE to see this. The moment Trump had enough of the gaslighting and walked out is pure fire — this is what fighting back against the fake news looks like. In this explosive clip, President Trump calls out NBC as a crooked, one-sided network and refuses to play NBC's rigged game any more. No more softball questions. No more pretending the 2020 election was fair. Just straight truth bombs that every conservative has been waiting for. We also cover: Spencer Pratt loses the Los Angeles mayoral race? Israel & Iran continue to shoot at each other. John Fetterman attacks “P-Hustle” s*xting scandal. AI just surpassed human traffic. Scott Pelley is the PROBLEM in journalism. If you're sick of the mainstream media's constant attacks on Trump and America First values, this video will fire you up. This isn't just another interview — it's a turning point moment that shows Trump is DONE tolerating the lies. Comment below RIGHT NOW: Was this Trump's best takedown yet? YES or NO? Should he keep going on these biased networks or ignore them completely? What was the craziest part of this interview? Drop your hottest take — I'm reading every single comment from patriots like you. 00:00 Pat Gray UNLEASHED! 00:18 New Pat Gray BINGO! Card 04:32 Iran Peace Deal Falling Apart 04:52 California in Trouble! 14:28 Out of Weapons against Iran? 16:53 Trump on U.S. Retrieving Nuclear Dust 18:16 Trump on Naval Blockade 19:21 Trump Asked Where the Leader of Iran is 21:21 Adviser to Iran's Supreme Leader on Negotiations 26:16 Price of Oil/Gas Rises Again 27:10 Trump on Treatment of J6 Protestors 34:16 Trump Walks Out of NBC Interview 37:50 Trump Asked about the New York Knicks 38:53 Enhanced Security for Madison Square Garden 41:34 Fat Five 48:59 Bots Taking Over the Internet! 53:37 John Fetterman's Thoughts on Graham Platner 1:04:47 More of John Fetterman & Graham Platner 1:06:01 Jeffy Brings Up the Tony Awards 1:06:53 Ellen DeGeneres & Portia de Rossi Return to U.S. 1:10:11 Pat Gray: The Neighborhood Gadfly 1:13:10 Interview with Scott Pelley 1:19:58 Todd Blanche's Fraud Update 1:23:13 H-1B Visa Fraud 1:28:22 Special Pat Gray UNLEASHED! Episode Later this Week 1:29:45 Debbie Dingell is Fed Up! 1:32:15 What Black People Think of Karmelo Anthony Trial Learn more about your ad choices. Visit megaphone.fm/adchoices

The McCullough Report with Dr. Peter McCullough – Dr. Peter McCullough and Brig. Gen. Blaine Holt challenge the WHO's hantavirus response, alleging mishandled cruise ship containment, ignored treatments, and a familiar crisis-to-vaccine playbook. Their discussion frames the outbreak as medical failure, political pressure, and psychological warfare, urging people to seek independent information and prepare emergency medical...